Institute of Developmental and Regenerative Medicine (IDRM)
Director
-
Paul Riley
BHF Professor of Regenerative Medicine & Chair of Development and Cell Biology
DPAG Principal Investigators
-
Sarah De Val
BHF Senior Fellow
-
Mathilda Mommersteeg
Associate Professor of Developmental and Regenerative Medicine
-
Filipa Simões
Principal Investigator
-
Nicola Smart
BHF Ian Fleming Fellow and Professor of Cardiovascular Science
-
Shankar Srinivas
Professor of Developmental Biology
-
Oliver Stone
Wellcome Trust Sir Henry Dale Fellow
What's new
©
Chris Price/Eveline James
The Institute of Developmental and Regenerative Medicine (IDRM) is a unique flagship institution, at the University of Oxford, dedicated to meeting an ambitious challenge: two thirds of all deaths world-wide are due to non-communicable diseases, many of which are cardiovascular, neurological or immune system disorders that have a developmental origin, representing an urgent unmet clinical need. The mission of the IDRM is the development of new drugs and therapeutic strategies to tackle these chronic illnesses.
At its core is a formal merger of developmental biology and regenerative medicine in the form of 15-20 world leading research groups comprising 240 cardiovascular, neuroscience and immunology scientists integrating their expertise to foster multidisciplinary collaborations.